1660.00GBp-0.90%Mkt Cap: 86.73M GBpP/E: 11.77Last update: 2026-06-01
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertilit…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap86.73M GBp
Enterprise Value82.21M GBp
Revenue (TTM)12.54M GBp
Gross Profit11.92M GBp
Net Income (TTM)7.58M GBp
Revenue/Share2.401 GBp
Last Price1660.00 GBp
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees12
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)11.77
P/E (Forward)0.09
PEG—
EV/EBITDA8.36
EV/Revenue6.55
P/S6.98
P/B7.93
EPS (TTM)1.41
EPS (Forward)179.30
52W Range
0.000055% of range3020.00
52W High3020.00 GBp
52W Low0.0000 GBp
Profitability
Gross Margin90.86%
Oper. Margin76.56%
EBITDA Margin78.45%
Profit Margin57.83%
ROE65.66%
ROA58.96%
Growth
Revenue Growth-8.50%
Earnings Growth-3.90%
Cash Flow & Leverage
Operating CF7.03M GBp
CapEx (TTM)19.19K GBp
FCF Margin52.59%
FCF Yield7.61%
Net Debt-5.30M GBp
Net Debt/EBITDA-0.54
Balance Sheet
Debt/Equity—
Current Ratio6.12
Quick Ratio5.76
Book Value/Sh2.113 GBp
Cash/Share1.015 GBp
Dividends
Fwd Div Rate1.500 GBp
Trail. Div Rate1.500 GBp
Div. Yield8.96%
5Y Avg Yield4.35%
Payout Ratio106.75%
Ex-Div DateApr 9, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)3900.00 GBp
Target Range3900.00 GBp – 3900.00 GBp
# Analysts1
Ownership
Shares Out.5.22M
Float4.14M
Insiders7.70%
Institutions65.21%
Technical
SMA 501669.50 (-0.6%)
SMA 2001920.47 (-13.6%)
Beta0.56
S&P 52W Chg27.94%
Avg Vol (30d)9.17K
Avg Vol (10d)9.03K
Technical Indicators
RSI (14)48.5
MACD-3.2033
MACD Signal-0.2224
MACD Hist.-2.9809
BB Upper1728.37 GBp
BB Middle1687.45 GBp
BB Lower1646.53 GBp
BB Width4.85%
ATR (14)159.71 GBp
Vol Ratio (20d)3.06x